COVID-19:ロシュの関節炎治療薬トシリズマブ:死亡リスクを軽減(動画): RECOVERY Data Shows Roche Tocilizumab Cuts Deaths in COVID-19 Patients: 恢复试验数据表明罗氏关节炎药物可减少住院的COVID-19患者的死亡 2021年02月22日By Tokio X'press flu, Health & Safety, Product Safety & Quality, Access to Health Care, Pharmaceutical COVID-19:イベルメクチン、ランダム化二重盲検治験:イスラエルSheba(動画): Randomized Double-Blinded Trial at Sheba Medical Center:Ivermectin: 舍巴医学中心的随机双盲临床试验:伊维菌素可从本质上降低COVID-19 2021年02月18日By Tokio X'press flu, Product Safety & Quality, Insuring Health & Demographic Risk, Opportunities in Nutrition & Health, Business Ethics, Pharmaceutical COVID-19: Appili、米国でファビピラビル治験:第3相試験募集(動画): Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir: Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新 2021年02月12日By Tokio X'press flu, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical COVID-19:ロボットでPCR検査数を大幅増:川崎重工が開発(動画): COVID-19: Significantly increase the PCR tests with robots: by KHI: COVID-19:大大增加了机器人进行PCR测试的次数:由川崎重工开发 2021年02月10日By Tokio X'press flu, 0.Pollution & Waste, 1.Human Capital, Labor Management, Health & Safety, Product Safety & Quality, monitor, medical service COVID-19:スロバキア、イベルメクチンを承認:EUで最初(動画): First EU Nation To Approve Ivermectin For Covid-19: 第一个欧盟国家批准伊维菌素用于Covid-19 2021年02月03日By Tokio X'press flu, Health & Safety, Access to Health Care, Pharmaceutical Posts navigation Page 1 … Page 34 Page 35 Page 36 … Page 107